← Back to Search

Radiation Therapy

HoloLens v2 for Breast Cancer

N/A

Waitlist Available

Led By Perry Johnson

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 12 months for trial accrual

Awards & highlights

Study Summary

This trial is testing whether a new system that uses mixed-reality technology is more accurate and efficient for setting up radiation therapy than the current IGRT system.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 12 months for trial accrual

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 12 months for trial accrual

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 months for trial accrual for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of computed tomography (CBCTs) a participant receives during radiation therapy treatment as quantified via counting the number used during the setup process.

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Mixed-reality guided patient setup-Group 2Experimental Treatment1 Intervention

During treatments 1-5, radiation therapists will use the hologram the investigators created to initially position the participant for treatment. The participant's final position will be obtained using a standard of care method. During treatments 6-10, radiation therapists will position the participant for treatment using the standard of care method.

Group II: Standard of Care-Group 1Placebo Group1 Intervention

During treatments 1-5, radiation therapists will position the participant for treatment using the standard of care method. During treatments 6-10, radiation therapists will use the hologram the investigators created to initially position the participant for treatment. The participant's final position will be obtained using a standard of care method.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HoloLens v2

2022

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,676 Total Patients Enrolled

13 Trials studying Breast Cancer

571 Patients Enrolled for Breast Cancer

Florida Breast Cancer FoundationUNKNOWN

2 Previous Clinical Trials

140 Total Patients Enrolled

Perry JohnsonPrincipal InvestigatorUniversity of Florida

Media Library

Mixed-Reality Guided Radiotherapy (Radiation Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05178927 — N/A

Breast Cancer Research Study Groups: Standard of Care-Group 1, Mixed-reality guided patient setup-Group 2

Breast Cancer Clinical Trial 2023: Mixed-Reality Guided Radiotherapy Highlights & Side Effects. Trial Name: NCT05178927 — N/A

Mixed-Reality Guided Radiotherapy (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05178927 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still open to participants?

"Clinicaltrials.gov reflects that this clinical trial is still in its recruitment phase, with the original posting dating back to August 2nd 2022 and a recent update made on August 5th of the same year."

Answered by AI

To what extent has enrollment in this trial been successful?

"Affirmative. Clinicaltrials.gov indicates that this study, initially posted on August 2nd 2022, is presently seeking applicants. A total of 24 people must be recruited from a single medical centre."

Answered by AI

Does this research involve participants of any age greater than fifty?

"To qualify for this trial, patients should be between the ages of 18 and 100. Separately, there are 52 clinical trials developed specifically for individuals under the age of 18 and 1335 studies targeting those over 65 years old."

Answered by AI

How can I become part of this clinical experiment?

"To gain admission to this medical trial, individuals must have been diagnosed with breast cancer and fall in the age range of 18-100. There is a need to recruit 24 patients for the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization

2022. "UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05178927.